Skip to main content
Vaxart, Inc. (VXRT)
NASDAQ: VXRT · Real-Time Price · USD
0.721
-0.039 (-5.12%)
Mar 5, 2026, 4:00 PM EST - Market closed

Vaxart Revenue

Vaxart had revenue of $72.41M in the quarter ending September 30, 2025, with 1,367.93% growth. This brings the company's revenue in the last twelve months to $148.20M, up 784.27% year-over-year. In the year 2024, Vaxart had annual revenue of $28.70M with 288.94% growth.

Revenue (ttm)
$148.20M
Revenue Growth
+784.27%
P/S Ratio
1.17
Revenue / Employee
$1,411,467
Employees
105
Market Cap
173.15M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202428.70M21.32M288.94%
Dec 31, 20237.38M7.27M6,796.26%
Dec 31, 2022107.00K-785.00K-88.00%
Dec 31, 2021892.00K-3.15M-77.95%
Dec 31, 20204.05M-5.82M-58.97%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Compugen 72.76M
Tonix Pharmaceuticals Holding 10.30M
Molecular Partners AG 856.30K
SAB Biotherapeutics 114.70K
NeOnc Technologies Holdings 59.99K
Revenue Rankings

VXRT News

More News